| Factor Information | |
|---|---|
| Data ID | 1255 |
| Factor | Mortality of CHD in the postneonatal (28-364 day) period in different ethnic |
| Description | The racial disparity was wider in the postneonatal period (2.08 per 10 000 vs 1.42 per 10 000; RR, 1.53; 95% CI, 1.29-1.83) compared with the neonatal period (1.70 per 10 000 vs 1.44 per 10 000; RR, 1.20; 95% CI, 0.99-1.45). |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | Compare the mortality rate in the postneonatal period and the neonatal period. |
| OR | 1.53 |
| Conclusion | The racial disparity in infant mortality rate due to CHD among term infants with US-born mothers is driven predominately by the postneonatal survival disadvantage of African-American infants. Commonly cited individuallevel risk factors partly explain this phenomenon. The study is limited by the lack of information on neighborhood factors. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 508 |
| CHD Type | NA |
| CHD Subtype | LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
| Reference | |
|---|---|
| PMID | 27836287 |
| Year | 2016 |
| Title | African-American:White Disparity in Infant Mortality due to Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | infancy | |
| Source | Health Statistics linked live birth–infant death cohort files | |
| Region | USA | |
| Method | stratified logistic regression analyses | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD for African-American infants(Treatment) | infants with non-Hispanic white(Control) |
| Number | 163 | 766 |
| Age | 28-364 day | 28-364 day |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 2.08 per 10 000 live births | 1.42 per 10 000 live births |
